Close

Notable Analyst Rating Changes 09/11: (BMY) (SYNC) (JAZZ) Upgraded; (SIRI) (TIBX) (GNOM) Downgraded

September 11, 2012 10:37 AM EDT
UPGRADES
Goldman Sachs upgrades Bristol-Myers Squibb Co. (NYSE: BMY) from Buy to Conviction Buy, moving its price target from $38 to $40. Click Here for more color.

Citi raises Synacor (Nasdaq: SYNC) from Sell to Neutral.

Cowen raises Jazz Pharmaceuticals (Nasdaq: JAZZ) from Neutral to Outperform.

Goldman Sachs added Catamaran (Nasdaq: CTRX) to its Conviction Buy List with a price target of $120. Click Here for more color.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES
Gabelli chops Sirius XM (Nasdaq: SIRI) from Hold to Sell. Click Here for more color.

ThinkEquity downgrades Tibco Software, Inc. (Nasdaq: TIBX) from Buy to Hold, moving its price target from $36 to $32. Click Here for more color.

Baird drops Complete Genomic (Nasdaq: GNOM) from Outperform to Neutral with a price target of $3.

Brean Murray Carret & Co. lowers Coach (NYSE: COH) from Buy to Hold.

For daily real-time Downgrades go to http://www.streetinsider.com/downgrades

NEW COVERAGE
Jefferies initiates Clean Energy Fuels (Nasdaq: CLNE) with a Hold and $15 price target.

Credit Suisse assumes Gold Fields (NYSE: GFI) at Neutral.

Wunderlich Securities starts Intrepid Potash (NYSE: IPI) with a Buy and $26.50 target.

Credit Suisse reinstates Johnson & Johnson (NYSE: JNJ) at Neutral.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Goldman Sachs Conviction Buy List, Credit Suisse, Brean Murray Carret & Co., Citi, Jefferies & Co, Robert W Baird, ThinkEquity, Notable Analyst Rating Changes, Cowen & Co, Wunderlich Securities